The present invention is directed to L proline and citric acid co crystals of (2S 3R 4R 5S 6R) 2 (3 ((5 (4 fluorophenyl)thiophen 2 yl)methyl) 4 methylphenyl) 6 (hydroxymethyl)tetrahydro 2H pyran 3 4 5 triol pharmaceutical compositions containing said co crystals and their use in the treatment glucose related disorders such as Type 2 diabetes mellitus and Syndrome X.
展开▼
机译:本发明涉及(2S 3R 4R 5S 6R)2(3(((5(4-氟苯基)噻吩2基)甲基)4甲基苯基)6(羟甲基)四氢2H吡喃3 L 4的L脯氨酸和柠檬酸共晶体含有所述共晶体的三醇药物组合物及其在治疗葡萄糖相关疾病例如2型糖尿病和X综合征中的用途。
展开▼